Prairiewood Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,227
Closed -$358K 80
2025
Q2
$358K Sell
3,227
-1,029
-24% -$110K 0.13% 56
2025
Q1
$477K Sell
4,256
-1,853
-30% -$191K 0.19% 51
2024
Q4
$564K Sell
6,109
-424
-6% -$38.2K 0.24% 47
2024
Q3
$548K Sell
6,533
-109
-2% -$8.32K 0.23% 50
2024
Q2
$456K Sell
6,642
-1,329
-17% -$88.7K 0.22% 55
2024
Q1
$584K Sell
7,971
-596
-7% -$45.8K 0.27% 49
2023
Q4
$694K Buy
8,567
+3
+0% +$233 0.36% 44
2023
Q3
$642K Sell
8,564
-1,036
-11% -$79.7K 0.42% 42
2023
Q2
$740K Sell
9,600
-731
-7% -$58.3K 0.5% 38
2023
Q1
$857K Sell
10,331
-528
-5% -$43.7K 0.58% 30
2022
Q4
$932K Sell
10,859
-2,386
-18% -$189K 0.68% 31
2022
Q3
$817K Sell
13,245
-441
-3% -$27.8K 0.67% 34
2022
Q2
$846K Sell
13,686
-260
-2% -$16.1K 0.67% 33
2022
Q1
$829K Buy
13,946
+110
+0.8% +$7.03K 0.58% 34
2021
Q4
$1M Sell
13,836
-338
-2% -$23.3K 0.79% 31
2021
Q3
$990K Buy
14,174
+3
+0% +$211 0.81% 34
2021
Q2
$976K Buy
14,171
+262
+2% +$17.5K 0.83% 36
2021
Q1
$899K Buy
+13,909
New +$897K 0.82% 38

Other funds holding GILD

Prairiewood Capital's GILD Position: Q3 2025 in Review

Prairiewood Capital sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,227 shares — an estimated $358K sold.

Prairiewood Capital first reported a position in GILD in Q1 2021 and held it in 18 quarters. The position peaked at $1M in Q4 2021. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Prairiewood Capital reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Prairiewood Capital sold 3,227 Gilead Sciences shares in Q3 2025, an estimated $358K.
  • Prairiewood Capital first reported a position in Gilead Sciences in Q1 2021 and held it in 18 quarters.
  • Prairiewood Capital's Gilead Sciences position peaked at $1M in Q4 2021.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Prairiewood Capital's 13F filing for Q3 2025, filed 14 Oct 2025.